Author
Listed:
- Yuki Ohta
(Keio University School of Medicine)
- Masayuki Fujii
(Keio University School of Medicine)
- Sirirat Takahashi
(Keio University School of Medicine)
- Ai Takano
(Keio University School of Medicine)
- Kosaku Nanki
(Keio University School of Medicine
Keio University School of Medicine)
- Mami Matano
(Keio University School of Medicine)
- Hikaru Hanyu
(Keio University School of Medicine)
- Megumu Saito
(Keio University School of Medicine
Fujii Memorial Research Institute, Otsuka Pharmaceutical Company)
- Mariko Shimokawa
(Keio University School of Medicine)
- Shingo Nishikori
(Fujii Memorial Research Institute, Otsuka Pharmaceutical Company)
- Yoshiko Hatano
(Keio University School of Medicine)
- Ryota Ishii
(University of Tsukuba)
- Kazuaki Sawada
(Keio University)
- Akihito Machinaga
(KAN Research Institute)
- Wataru Ikeda
(KAN Research Institute)
- Takeshi Imamura
(Ehime University Graduate School of Medicine)
- Toshiro Sato
(Keio University School of Medicine)
Abstract
Cancer relapse after chemotherapy remains a main cause of cancer-related death. Although the relapse is thought to result from the propagation of resident cancer stem cells1, a lack of experimental platforms that enable the prospective analysis of cancer stem cell dynamics with sufficient spatiotemporal resolution has hindered the testing of this hypothesis. Here we develop a live genetic lineage-tracing system that allows the longitudinal tracking of individual cells in xenotransplanted human colorectal cancer organoids, and identify LGR5+ cancer stem cells that exhibit a dormant behaviour in a chemo-naive state. Dormant LGR5+ cells are marked by the expression of p27, and intravital imaging provides direct evidence of the persistence of LGR5+p27+ cells during chemotherapy, followed by clonal expansion. Transcriptome analysis reveals that COL17A1—a cell-adhesion molecule that strengthens hemidesmosomes—is upregulated in dormant LGR5+p27+ cells. Organoids in which COL17A1 is knocked out lose the dormant LGR5+p27+ subpopulation and become sensitive to chemotherapy, which suggests that the cell–matrix interface has a role in the maintenance of dormancy. Chemotherapy disrupts COL17A1 and breaks the dormancy in LGR5+p27+ cells through FAK–YAP activation. Abrogation of YAP signalling prevents chemoresistant cells from exiting dormancy and delays the regrowth of tumours, highlighting the therapeutic potential of YAP inhibition in preventing cancer relapse. These results offer a viable therapeutic approach to overcome the refractoriness of human colorectal cancer to conventional chemotherapy.
Suggested Citation
Yuki Ohta & Masayuki Fujii & Sirirat Takahashi & Ai Takano & Kosaku Nanki & Mami Matano & Hikaru Hanyu & Megumu Saito & Mariko Shimokawa & Shingo Nishikori & Yoshiko Hatano & Ryota Ishii & Kazuaki Saw, 2022.
"Cell–matrix interface regulates dormancy in human colon cancer stem cells,"
Nature, Nature, vol. 608(7924), pages 784-794, August.
Handle:
RePEc:nat:nature:v:608:y:2022:i:7924:d:10.1038_s41586-022-05043-y
DOI: 10.1038/s41586-022-05043-y
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:608:y:2022:i:7924:d:10.1038_s41586-022-05043-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.